BRIEF published on 04/29/2026 at 05:15, 4 months 13 days ago Silver Spruce Resources Inc. ajourne l'assemblée des actionnaires Projets D'exploration Assemblée Générale Des Actionnaires Ajournement Ressources Sur L'épinette Argentée Procuration De Vote
BRIEF published on 04/29/2026 at 04:55, 4 months 13 days ago Alaska Energy Metals Extends Marketing Services Agreement TSX Venture Exchange Investor Relations Marketing Agreement Alaska Energy Metals Capital Gain Media
BRIEF published on 04/29/2026 at 04:55, 4 months 13 days ago Alaska Energy Metals prolonge son accord de services de commercialisation Bourse De Croissance TSX Relations Avec Les Investisseurs Accord De Commercialisation Métaux Énergétiques De L'Alaska Capital Gain Media
BRIEF published on 04/29/2026 at 02:30, 4 months 13 days ago Organto Foods Reports Record Fiscal 2025 Financial Results Financial Results Sales Growth Organic Foods Net Loss Debt Restructuring
BRIEF published on 04/29/2026 at 02:30, 4 months 13 days ago Organto Foods annonce des résultats financiers records pour l'exercice 2025. Résultats Financiers Croissance Des Ventes Perte Nette Restructuration De La Dette Aliments Biologiques
BRIEF published on 04/29/2026 at 01:35, 4 months 13 days ago First Helium Inc. Announces Private Placement to Raise C$2 Million Private Placement Insider Participation Regulatory Approvals First Helium Worsley Project
BRIEF published on 04/29/2026 at 01:35, 4 months 13 days ago First Helium Inc. annonce un placement privé pour lever 2 millions de dollars canadiens Placement Privé Approbations Réglementaires Participation Des Initiés Premier Hélium Projet Worsley
BRIEF published on 04/29/2026 at 00:25, 4 months 13 days ago Fountain Asset Corp. Reports 2025 Financial Results Net Asset Value Investment Performance Operating Expenses Financial Results 2025 Fountain Asset Corp.
BRIEF published on 04/29/2026 at 00:25, 4 months 13 days ago Fountain Asset Corp. publie ses résultats financiers pour 2025 Valeur Nette D'actif Performance Des Investissements Résultats Financiers 2025 Frais D'exploitation Fountain Asset Corp.
BRIEF published on 04/29/2026 at 00:05, 4 months 13 days ago LIR Life Sciences Initiates Ex Vivo Study on Protamine's Efficacy in Transdermal Delivery Ex Vivo Study Needle-free Delivery Protamine Enhancement Transdermal Transport Therapeutic Molecules
Published on 09/12/2026 at 02:35, 17 hours 7 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 20 hours 42 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 21 hours 37 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 22 hours 17 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 hour 52 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 12 hours 12 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 21 hours 27 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 21 hours 32 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 23 hours 58 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
